| Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma |
NCT06208540: Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants |
|
|
| Completed | 4 | 160 | RoW | Cerebrolysin, Active arm, olfactory and gustatory trainings, controls | Sherifa Ahmed Hamed | Post-covid-19 Persistent Smell and Taste Disorders | 04/24 | 05/24 | | |
MI22-00013, NCT06273020: Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke |
|
|
| Recruiting | 4 | 60 | RoW | Cerebrolysin, Brain-MRI with contrast after 10-14 days of cerebrolysin | Hospital Universitario Dr. Jose E. Gonzalez, Ever Neuro Pharma GmbH | Ischemic Stroke, Acute, Diabetes Mellitus, Type 2, Blood Brain Barrier | 11/24 | 12/24 | | |
NCT04913831: Effects of Cerebrolysin on Level of Consciousness and Brain Metabolism in Disorder of Consciousness After Stroke: Single Center Randomized Controlled Study |
|
|
| Recruiting | 4 | 30 | RoW | Cerebrolysin, Placebo | Yonsei University | Stroke | 03/24 | 03/24 | | |
| Recruiting | 4 | 350 | Europe | Cerebrolysin, FPF (Fine Particle Fraction)-1070 | Poznan University of Medical Sciences | Acute Ischemic Stroke | 01/25 | 03/25 | | |
NCT04427241: Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness |
|
|
| Not yet recruiting | 4 | 12 | RoW | Cerebrolysin, Control | Konkuk University Medical Center, Ever Neuro Pharma GmbH | Disorder of Consciousness, Hemorrhagic Stroke | 07/25 | 12/25 | | |
2022-003382-38: Is Cerebrolysin efficient in neurorecovery after moderate-severe traumatic brain injury? Este Cerebrolysin eficient in neurorecuperare după traumatism cerebral moderat-sever? |
|
|
| Ongoing | 3 | 440 | Europe | Cerebrolysin, N07XXN3, Solution for injection/infusion, Cerebrolysin | FSNANO05012022, Fundatia pentru Studiul Nanoneurostiintelor si Neuroregenerarii | Moderate-severe traumatic brain injury Traumatism cerebral moderat-sever, Brain injury Traumatism cerebral, Diseases [C] - Nervous System Diseases [C10] | | | | |
NCT04904341: Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke. |
|
|
| Recruiting | 3 | 50 | Europe | Cerebrolysin | Military Institute of Medicine, Poland, Brainomix Limited | Stroke, Ischemic, Stroke, Acute, Stroke Sequelae | 12/23 | 12/24 | | |
NCT06052787: Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU |
|
|
| Recruiting | 3 | 150 | RoW | Cerebrolysin, amantadine sulfate, PK-MERZ | Ain Shams University | Traumatic Brain Injury | 03/25 | 09/25 | | |
NCT05124353: Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT |
|
|
| Recruiting | 2/3 | 100 | Europe | Cerebrolysin, neuroprotective treatment | Pomeranian Medical University Szczecin | Stroke, Acute, Ischemic | 04/23 | 04/23 | | |
2019-001799-12: A clinical study on stimulating the brain to improve the function of a stroke-damaged arm Eine klinische Studie über die Stimulierung des Gehirns zur Funktionsverbesserung des durch einen Schlaganfall geschädigten Armes |
|
|
| Not yet recruiting | 2 | 90 | Europe | Cerebrolysin, Concentrate for solution for infusion, Cerebrolysin® - parenteral solution | EVER Neuro Pharma GmbH, EVER Neuro Pharma GmbH, VASCage GmbH | Subacute and chronic stroke, Medical condition several months after stroke, Diseases [C] - Nervous System Diseases [C10] | | | | |
| Recruiting | 2 | 30 | RoW | Cerebrolysin, Renacenz, 0.9 % NaCl, Sodium Chloride | Ever Neuro Pharma GmbH, idv Datenanalyse & Versuchsplanung, XClinical GmbH | Cadasil | 03/26 | 12/26 | | |
NCT05821075: Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy |
|
|
| Recruiting | 1/2 | 90 | RoW | Prednisolone, Cerebrolysin | October 6 University | Bell Palsy | 10/24 | 12/24 | | |
NCT06339411: Exploring Cerebrolysin in Late Thrombectomy for Stroke: Blood-brain Barrier Biomarkers and Imaging Insights |
|
|
| Not yet recruiting | 1 | 100 | NA | Cerebrolysin | Chang Gung Memorial Hospital | Acute Ischemic Stroke | 12/26 | 07/27 | | |
NCT06489925: Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion |
|
|
| Not yet recruiting | 1 | 20 | NA | Cerebrolysin, Cerebrolysin® | University Hospital "Sestre Milosrdnice", Ever Neuro Pharma GmbH | Basilar Artery Occlusion, Posterior Circulation Brain Infarction | 05/25 | 05/26 | | |
NCT06429943: Cerebrolysin in SAH (Subarachnoidal Haemorrhage) - Observational Study |
|
|
| Completed | N/A | 47 | Europe | | Pomeranian Medical University Szczecin | SAH (Subarachnoid Hemorrhage) | 10/22 | 01/23 | | |
NCT05807503: Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury |
|
|
| Completed | N/A | 56 | Europe | Cerebrolysin | Pomeranian Medical University Szczecin | TBI (Traumatic Brain Injury) | 10/22 | 11/22 | | |
C-REGS2, NCT03480698: Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness |
|
|
| Active, not recruiting | N/A | 1851 | Europe | Cerebrolysin | Ever Neuro Pharma GmbH, IDV Data analysis and study planning Dr. Rahlfs | Acute Ischemic Stroke | 04/24 | 10/24 | | |
| Enrolling by invitation | N/A | 100 | Europe | Cerebrolysin | Medical University of Lublin | Neurocognitive Disorders, Surgery-Complications, Critical Illness, Brain Damage, Cardiac Disease | 06/24 | 12/24 | | |
NCT06677502: Cerebrolysin in Critically Ill Patients With Delirium |
|
|
| Enrolling by invitation | N/A | 500 | Europe | Cerebrolysin, Saline Solution - IV | Medical University of Lublin | Cognitive Impairment | 06/25 | 12/25 | | |
NCT06070753: A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT) |
|
|
| Recruiting | N/A | 30 | RoW | Cerebrolysin, Abrineurin | Shaare Zedek Medical Center | Acute Ischemic Stroke | 06/24 | 12/24 | | |
